is the fda stopping compounded tirzepatide Compound versions of GLP-1 drugs for weight loss halted by Update I received today. :
Description
Oral Wegovy (Semaglutide Tablet): An FDA-approved oral GLP-1 receptor agonist that provides a non-injection alternative, using semaglutide to support sustainable weight loss

J.CurovicV

Includes unlimited free doctor consults to track progress and get refills if appropriate, 24/7 online care team and free shipping

Affordability and Access The cost of medications like Wegovy can be a concern for many people

Patients on lower-dose maintenance therapy